Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma

References

• Kim SK, Lim HK, Kim YH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics. 2003;23(1):107–121.
   PubMed Web of Science ®Google Scholar
• Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology. 2001;221(2):447–454.
   PubMed Web of Science ®Google Scholar
• Passera K, Selvaggi S, Scaramuzza D, et al. Radiofrequency ablation of liver tumors: quantitative assessment of tumor coverage through CT image processing. BMC Med Imaging. 2013;13(1):3.
   PubMed Web of Science ®Google Scholar
• Sakakibara M, Ohkawa K, Katayama K, et al. Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. AJR Am J Roentgenol. 2014;202(5):487–495.
   PubMed Web of Science ®Google Scholar
• Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasonud Med Biol. 2013;39(2):187–210.
   PubMed Web of Science ®Google Scholar
• Westwood M, Joore M, Grutters J, et al. Contrast enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrastenhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2013;17(16):1–243.
   Web of Science ®Google Scholar
• Wiesinger I, Wiggermann P, Zausig N, et al. Percutaneous treatment of malignant liver lesions: evaluation of success using contrast- enhanced ultrasound (CEUS) and perfusion software. Ultraschall Med. 2018;39(4):440–447.
   PubMed Web of Science ®Google Scholar
• Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol. 2003; 181(1):57–63.
   PubMed Web of Science ®Google Scholar
• Kisaka Y, Hirooka M, Kumagi T, et al. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int. 2006;26(10):1241–1247.
   PubMed Web of Science ®Google Scholar
• Numata K, Fukuda H, Morimoto M, et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol. 2012;81(10):2746–2753.
   PubMed Web of Science ®Google Scholar
• Hao Y, Numata K, Ishii T, et al. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma. World J Gastroenterol. 2017;23(17):3111–3121.
   PubMed Web of Science ®Google Scholar
• Nishigori S, Numata K, Irie K, et al. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography. J Med Ultrasonics. 2018;45(3):405–415.
   PubMed Web of Science ®Google Scholar
• Makino Y, Imai Y, Igura T, et al. Feasibility of extracted-overlay fusion imaging for intraoperative treatment evaluation of radiofrequency ablation for hepatocellular carcinoma. Liver Cancer. 2016;5(4):269–279.
   PubMed Web of Science ®Google Scholar
• Ma QP, Xu EJ, Zeng QJ, et al. Intraprocedural computed tomography/magnetic resonance-contrast-enhanced ultrasound fusion imaging improved thermal ablation effect of hepatocellular carcinoma: comparison with conventional ultrasound. Hepatol Res. 2019;49(7):799–809.
   PubMed Web of Science ®Google Scholar
• Xu EJ, Lv SM, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia. 2018;34(6):870–876.
   PubMed Web of Science ®Google Scholar
• Kudo M, Matsui O, Izumi N, et al. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer. 2014;3(3–4):458–468.
   PubMed Web of Science ®Google Scholar
• Sugimori K, Numata K, Okada M, et al. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US. J Med Ultrasonics. 2017;44(1):89–100.
   PubMed Web of Science ®Google Scholar
• Numata K. Advances in ultrasound systems for hepatic lesions in Japan. J Med Ultrasonics. 2015;42(3):297–301.
   PubMed Web of Science ®Google Scholar
• Numata K, Fukuda H, Miwa H, et al. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. Eur J Radiol. 2014;83(1):95–102.
   PubMed Web of Science ®Google Scholar
• Numata K, Fukuda H, Nihonmatsu H, et al. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease. Abdom Imaging. 2015;40(7):2372–2383.
   PubMedGoogle Scholar
• Ishii T, Numata K, Hao Y, et al. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol. 2017;89:234–241.
   PubMed Web of Science ®Google Scholar
• Kunishi Y, Numata K, Morimoto M, et al. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. AJR Am J Roentgenol. 2012;198(1):106–114.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, et al. Radiofrequency ablation for hepatocellular carcinoma:the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol. 2013;48(8):951–965.
   PubMed Web of Science ®Google Scholar
• Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991. p. 1–611.
   Google Scholar
• Seo J, Koizumi N, Funamoto T, et al. Visual serving for a US-guided therapeutic HIFU system by coagulated lesion tracking: a phantom study. Int J Med Robotics Comput Assist Surg. 2011;7(2):237–247.
   PubMed Web of Science ®Google Scholar
• Cha DI, Lee MW, Song KD, et al. A prospective comparison between auto-registration and manual registration of real-time ultrasound with MR images for percutaneous ablation or biopsy of hepatic lesions. Abdom Radiol. 2017;42(6):1799–1808.
   PubMed Web of Science ®Google Scholar
• Huang Q, Zeng Z. A review on real-time 3d ultrasound imaging technology. Biomed Res Int. 2017;2017:1–20.
   Web of Science ®Google Scholar